Benoit Gueugnon, Chief Financial Officer - Tilak Healthcare at Tilak Healthcare

Benoit Gueugnon

Chief Financial Officer - Tilak Healthcare at Tilak Healthcare | Paris, Île-de-France, France

Profile last verified August 2026
Financial Services Verified Profile Paris, Île-de-France, France Ecole de Management de Normandie
Verified

Work Email

***@em-normandie.fr

Last verified September 2026

Phone Number

+33*****

France • Mobile

Free account · No credit card · 5 profiles/month

Benoit Gueugnon Socials
Benoit Gueugnon Work Experience

Chief Financial Officer at Quantum Genomics in January 2020 - Present

Chief Financial Officer - Tilak Healthcare at Tilak Healthcare in November 2023 - Present

Head of Finance at Quantum Genomics in July 2018 - January 2020

See more See less

Auditeur Financier Senior at KPMG France in January 2015 - July 2018

Auditeur financier at KPMG France in September 2013 - June 2014

Contrôleur de gestion at Holcim in June 2012 - August 2012

Benoit Gueugnon Education

Ecole de Management de Normandie, January 2009 to January 2016

University of Portsmouth, January 2011 to January 2012

Benoit Gueugnon Skills
corporate finance accounting Management fund raising Investor relation Contrôle de gestion SAP ERP Levée de fonds Finance d’entreprise Audit interne levée de fonds M&A Finance OPS Relation investisseurs Gestion de la trésorerie Indicateurs clés de performance FP&A Comptabilité
About Benoit Gueugnon’s Current Company
Tilak Healthcare

The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class: BAPAIs for BrainAminopeptidase A Inhibitors. We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure. High blood pressure remains a major public health concern. Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A. The mid-term strategic objective of the company is to sign partnership agreements with major pharmaceutical companies which will take over and bring the products from the BAPAI technology to the market.

Discover more about Tilak Healthcare
Benoit Gueugnon’s Colleagues
Bruno Besse

Bruno Besse

Paris, Île-de-France, France

Chief Medical Officer at Quantum Genomics

Praticien Attaché - Cardiologie at Hôpital Européen Georges Pompidou
(September 2000 – Present)

JR

Jean-pierre Riffaud

Greater Paris Metropolitan Region

Chef de projet senior chez Quantum Genomics

Chef de projet senior at Quantum Genomics
(Present)

YS

Yohann Segard

Antony, Île-de-France, France

Employé administratif chez Quantum Genomics

Employé administratif at Quantum Genomics
(Present)

Search similar profiles
Frequently asked questions about Benoit Gueugnon

What is Benoit Gueugnon email address?

Email Benoit Gueugnon at [email protected] and [email protected]. This email is the most updated Benoit Gueugnon's email found in 2026.

How to contact Benoit Gueugnon?

To contact Benoit Gueugnon send an email to [email protected] or [email protected].

What company does Benoit Gueugnon work for?

Benoit Gueugnon works for Tilak Healthcare.

What is Benoit Gueugnon's role at Tilak Healthcare?

Benoit Gueugnon is Chief Financial Officer - Tilak Healthcare

What industry does Benoit Gueugnon work in?

Benoit Gueugnon works in the Financial Services industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free